Look duration at the face as a developmental endophenotype: elucidating pathways to autism and ADHD. by Gui, Anna et al.
Special Issue Article
Look duration at the face as a developmental endophenotype:
elucidating pathways to autism and ADHD
Anna Gui1, Luke Mason1, Teodora Gliga2, Alexandra Hendry3, Jannath Begum Ali1, Greg Pasco4, Elizabeth Shephard4,
Charles Curtis5, Tony Charman4, Mark H. Johnson6,1, Emma Meaburn1, Emily J. H. Jones1 and the BASIS-STAARS team
1Department of Psychological Sciences, Birkbeck College, University of London, London, UK; 2School of Psychology, University of East Anglia, Norwich, UK;
3Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom; 4Department of Psychology, Institute of Psychiatry, Psychology &
Neuroscience, King’s College London, Norwich, UK; 5Social, Genetic and Developmental Psychiatry Centre, King’s College London, London UK and 6Department of
Psychology, Cambridge University, Cambridge, UK
Abstract
Identifying developmental endophenotypes on the pathway between genetics and behavior is critical to uncovering the mechanisms under-
lying neurodevelopmental conditions. In this proof-of-principle study, we explored whether early disruptions in visual attention are a
unique or shared candidate endophenotype of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).
We calculated the duration of the longest look (i.e., peak look) to faces in an array-based eye-tracking task for 335 14-month-old infants
with and without first-degree relatives with ASD and/or ADHD. We leveraged parent-report and genotype data available for a proportion of
these infants to evaluate the relation of looking behavior to familial (n = 285) and genetic liability (using polygenic scores, n = 185) as well as
ASD and ADHD-relevant temperament traits at 2 years of age (shyness and inhibitory control, respectively, n = 272) and ASD and ADHD
clinical traits at 6 years of age (n = 94).
Results showed that longer peak looks at the face were associated with elevated polygenic scores for ADHD (β = 0.078, p = .023), but not
ASD (β = 0.002, p = .944), and with elevated ADHD traits in mid-childhood (F(1,88) = 6.401, p = .013, h2p=0.068; ASD: F (1,88) = 3.218, p
= .076), but not in toddlerhood ( ps > 0.2). This pattern of results did not emerge when considering mean peak look duration across face and
nonface stimuli. Thus, alterations in attention to faces during spontaneous visual exploration may be more consistent with a developmental
endophenotype of ADHD than ASD. Our work shows that dissecting paths to neurodevelopmental conditions requires longitudinal data
incorporating polygenic contribution, early neurocognitive function, and clinical phenotypic variation.
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Introduction
One of the big questions in psychiatry broadly is why conditions
often overlap and whether this overlap reflects shared underlying
mechanisms (Gandal et al., 2018; Thapar, Cooper, & Rutter, 2016;
The Brainstorm Consortium, 2018). It could be that there
are common environmental or genetic factors that trigger compa-
rable compensatory or adaptive brain processes subsequently
emerging as psychiatric conditions at a phenotypic level (with
specificity depending on interactions with other factors, Bishop,
2010; Frankenhuis et al., 2016; Johnson, 2017; Johnson et al.,
2015; Karmiloff-Smith et al., 2014; Thomas et al., 2016).
Alternatively, it could be that symptoms of one condition lead
to a behavioral profile characteristic of another (Bishop, 2017;
Neale & Kendler, 1995; Sokolova et al., 2017). Addressing such
questions requires a developmental approach, since genetic and
environmental risk factors act prenatally and disorders are com-
monly only diagnosed in childhood or later (Johnson, Jones, &
Gliga, 2015). The field of developmental psychopathology has
long focused on uncovering the origins and course of “individual
patterns of behavioral maladaptation” (Sroufe & Rutter, 1984)
through a multidisciplinary integration of research approaches
across the lifespan. Within this framework, mapping the “similar-
ities and differences underlying diverse groups of risks and
pathology” (Cicchetti, 1993, p. 474) is critical both scientifically
and clinically.
From a clinical perspective, common vulnerability, protective
or resilience factors could be an efficient target for prodromal
screening procedures and non-specific interventions (Cicchetti,
1993). A focus on shared vulnerability is central to the Early
Symptomatic Syndromes Eliciting Neurodevelopmental Clinical
Examinations (ESSENCE) framework, which advocates for clinical
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examination and intervention targeting a range of behavioral
problems emerging before age 3–5 years without the need to dis-
sect conditions at early stages (Gillberg, 2010). Similarly, the
Research Domain Criteria (RDoC) framework encourages
researchers to focus their efforts on investigating transdiagnostic
phenotypes, as a classification system of mental conditions
based on biobehavioral dimensions cutting across current diag-
nostic categories might better reflect our understanding of mech-
anisms underlying psychopathology (Cuthbert & Insel, 2013).
Conversely, identifying condition-specific etiological causes of
neurobehavioral manifestations in some cases is essential to
implement successful interventions, for example when medica-
tions targeting defined biological systems are available (Thapar
et al., 2016). With regards to protective factors, the developmental
psychopathology framework stresses the importance of identify-
ing resilience factors that may contribute to positive adaption in
the face of developmental risk and could be targets for preventa-
tive intervention programs (Cicchetti, 2013). However, it is
important to note that adaptation may in some cases result in
the amplification of behavioral differences and so interventions
must be carefully designed (Johnson et al., 2015).
Scientifically, studying whether early signs of behavioral varia-
tion lie on condition-specific or general pathways is crucial to
understand developmental processes leading to the manifestation
of clinical symptoms (Cicchetti, 1993; Dick, 2018). This allows us
to start to distinguish brain systems that might act as protective or
resilience factors against a range of developmental risk from sys-
tems that act more specifically to produce a specific behavioral
outcome (Johnson, 2012; Johnson, Gliga, Jones, & Charman,
2014). Observing pathways prior to symptoms is a powerful
approach to disentangle whether different conditions are associ-
ated in terms of early signs and vulnerability factors (Elsabbagh
& Johnson, 2010; Jeste & Geschwind, 2014; Wade, Prime, &
Madigan, 2015). Conversely, if we could separate out patterns of
cognitive, biological, or behavioral features of different conditions
even in infancy, then this would suggest that they may be etiolog-
ically dissociable (Johnson et al., 2014). In this proof-of-principle
study we combined longitudinal behavioral and genotype data (a
multimodal approach considered essential to making progress in
developmental psychopathology; Cicchetti, 2013) to make a step
forward in understanding developmental processes underlying
the emergence of neurodevelopmental conditions.
Autism spectrum disorder (ASD) and attention-deficit/
hyperactivity disorder (ADHD) are two of the most common
neurodevelopmental conditions. ASD diagnosis is assigned typi-
cally between 3 and 5 years of age (Baio et al., 2018; Brett,
Warnell, McConachie, & Parr, 2016) based on the presence of
impairments in social interaction and communication, and
restricted interests and repetitive behaviors as well as signs of
sensory hyper- or hyposensitivity (American Psychiatric
Association, 2013). ADHD is defined through clinical observation
of the emergence, typically after 6 years of age (Halperin & Marks,
2019), of two types of behavioral manifestations: inattentiveness
and/or hyperactivity and impulsiveness (American Psychiatric
Association, 2013). Twin, family, and DNA-based studies showed
that both ASD and ADHD are highly heritable, indicating
that genetic factors explain most of the liability of these conditions
(Hidalgo-Lopez, Gomez-Alzate, Garcia-Valencia, & Palacio-Ortiz,
2019; Larsson, Chang, D-Onofrio, & Lichtenstein, 2014; Miller
et al., 2019; Tick, Bolton, Happé, Rutter, & Rijsdijk, 2016).
Substantial clinical overlap has been found between ADHD
and other neurodevelopmental conditions, in particular ASD
(Hollingdale, Woodhouse, Young, Fridman, & Mandy, 2019;
Lai et al., 2019). Importantly, between 20 and 50% of children
who have received a diagnosis of ADHD also meet criteria for
ASD and between 30 and 80% of children who have been diag-
nosed with ASD also meet criteria for ADHD, raising the question
whether common causal mechanisms might underlie behavioral
manifestations of the two neurodevelopmental conditions
(Rommelse, Franke, Geurts, Hartman, & Buitelaar, 2010).
Symptoms of both ADHD and ASD likely result from a com-
plex interaction between emerging neurodevelopmental vulnera-
bilities and aspects of the child’s prenatal and postnatal
environment (Geschwind, 2011; Thapar, Cooper, Eyre, &
Langley, 2013). However, research so far has produced mixed evi-
dence on whether common or distinct developmental pathways
underlie these conditions (Johnson et al., 2014; Visser,
Rommelse, Greven, & Buitelaar, 2016). On the one hand, twin
and molecular research studies indicate that phenotypic overlap
between the two conditions is partly explained by shared genetic
factors (Rommelse et al., 2010; Stergiakouli et al., 2017). Similarly,
familial studies indicate that family members of people with ASD
show increased levels of ADHD symptoms, compared to relatives
of individuals with no neurodevelopmental condition (Chien
et al., 2017). This suggests that familial factors are likely to have
a general effect on ASD and ADHD symptomatology, possibly
due to shared attention-related problems linked to pleiotropic
risk factors underlying attention and social difficulties (Sokolova
et al., 2017). On the other hand, specific genetic and environmen-
tal influences have been found for the two conditions, suggesting
that they are partly etiologically distinct and that co-occurrence of
features, rather than complete comorbidity, is often observed in
individuals who show both symptoms of ASD and ADHD
(Ronald, Larsson, Anckarsater, & Lichtenstein, 2014; The
Brainstorm Consortium, 2018). Evaluating whether early pheno-
types reflecting genetic effects are specifically associated with
ASD versus ADHD could shed light on the mechanisms underly-
ing clinical manifestations of these two conditions and the role of
early factors contributing to increased susceptibility.
The concept of “developmental endophenotype”
In seeking to identify the factors that mediate between genetic
variation and later symptomatology, the developmental psychopa-
thology framework has several natural points of intersection
with the effort to identify endophenotypes in psychiatry.
Endophenotypes are conceptualized as quantitative measures
that are closer to the biological bases of the disorder or condition
than clinical phenotypes; these measures must be reliably quanti-
fiable, state-independent, that is they can be observed when clin-
ical symptoms are not, and they are found to a higher extent in
unaffected relatives of affected individuals than in the typical pop-
ulation (Gottesman & Gould, 2003). The concept of endopheno-
type in psychiatry has been introduced as a potential tool to help
resolve questions about etiological models, because it provides a
genetically tractable target lying in the gap between genetic liabil-
ity and neurodevelopmental process (Flint & Munafò, 2007).
Thus, both the concept of endophenotypes and the field of devel-
opmental psychopathology originated from the recognition that
linking the distal etiology of neurodevelopmental disorders to
their proximal symptoms required an intermediate level of analysis.
Since the original framework was proposed by Gottesman and
Gould (2003), the endophenotype construct has been revised to
improve its utility in clinical practice and scientific discovery
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(Iacono, Malone, & Vrieze, 2017). One approach is to test
whether endophenotypes share genetic bases with the psychiatric
phenotype through using molecular genetic data, such as poly-
genic risk scores (Dick, 2018; Iacono et al., 2017). In line with
the RDoC approach (Insel, 2014), it has been proposed that endo-
phenotypes should be tested for association with dimensional
traits and clinical characteristics, rather than limiting the analysis
to categorical Diagnostic and Statistical Manual of Mental
Disorders (DSM) diagnosis (Beauchaine & Constantino, 2017;
Iacono et al., 2017). Further, the criterion of state-independence
has been elaborated as the possibility that an endophenotype is
observed earlier in development than the behavioral manifestation
of a clinical condition (Flint & Munafò, 2007; Skuse, 2001). This
latter point resonates with the developmental psychopathology
approach, where there is explicit recognition of the need to
study age-dependent manifestations of particular characteristics
and how they may combine to produce cascading outcomes
(Cicchetti, 1993). Measures obtained at critical developmental
time-points that reflect emerging components of cognition or
affect and are linked to genetic effects have been defined as “devel-
opmental endophenotypes” (Johnson & Fearon, 2011). Studying
developmental endophenotypes in populations with a higher like-
lihood of developing a neurodevelopmental condition can help
understand risk and protective mechanisms underlying individual
variability in cognitive and affective functions and identify target
functions for early interventions (Green et al., 2017; Skuse, 2001).
Identifying developmental endophenotypes of ASD and ADHD
Prospective studies of infants with an older sibling with ASD have
uncovered a range of potential developmental endophenotypes
(Jones, Gliga, Bedford, Charman, & Johnson, 2014; Szatmari
et al., 2016). Infants with an older sibling with ASD are consid-
ered at elevated likelihood of neurodevelopmental conditions,
having a 20% chance of developing ASD themselves (Messinger
et al., 2013; Ozonoff et al., 2011), and up to a 30% chance of
developing related conditions (Charman et al., 2017; Ozonoff
et al., 2014). Such work has shown a range of early alterations
that could represent developmental endophenotypes, including
delayed attainment of motor milestones, faster head circumfer-
ence growth, different temperamental characteristics, and difficul-
ties in disengaging and maintaining attention (Johnson et al.,
2014). Infant sibling studies offer unique opportunities to investi-
gate the dynamic interaction between susceptibility and resilience
factors underlying developmental trajectories (Szatmari, 2018).
However, such studies thus far have typically focused on infants
with a familial history of ASD without specifically accounting
for the presence of related conditions like ADHD in the family.
Thus, the current literature does not allow us to evaluate whether
these measures reflect atypicalities that are involved in the path-
way to neurodevelopmental conditions in general, or whether
they indicate condition-specific signs of a diverse developmental
trajectory.
Measures of attention as potential developmental
endophenotypes
The present paper is a proof-of-principle study to explore how we
can study the specificity or universality of developmental endo-
phenotypes in the early emergence of ASD and ADHD. To do
this, we chose to focus on a domain that is closely linked to
both ASD and ADHD: attention. Visual attention is a domain-
general cognitive function which serves to prioritize processing
of certain stimuli over others in order to select environmental
information for learning and memory (Amso & Scerif, 2015;
Scerif, 2010). Importantly, attention is listed in the RDoC frame-
work as a construct of transdiagnostic relevance (Cuthbert &
Insel, 2013). In early development, changes in attention reflect
the gradual development of the interaction between neurocogni-
tive control mechanisms and salient perceptual characteristics of
the sensory world (Scerif, 2010). The development of attention
is influenced by the organization of the maturing brain so that
during the first year of life infants start to build the ability to
direct or inhibit attention on a volitional basis (endogenous atten-
tion). The study of individuals with rare monogenic disorders
such as Fragile X and Williams syndromes, which often present
with elevated ASD and/or ADHD traits, suggests that molecular
pathways involved in ASD and ADHD might disturb this process.
In fact, these syndromes are characterized by early disruptions of
the hierarchical organization of the neural networks underlying
the development of attention (Amso & Scerif, 2015; Atkinson &
Braddick, 2011). In line with this idea, shared genetic factors
have been found to underlie inattention and attentional switching
capacity in adults and children with co-occurring symptoms of
ASD and ADHD (Polderman et al., 2013; Sinzig, Morsch,
Bruning, Schmidt, & Lehmkuhl, 2008). Thus, correlates of atten-
tion could represent candidate developmental endophenotypes
for both ASD and ADHD, and early disruptions to attention
could theoretically contribute to the overlap between the two con-
ditions. However, to date there is very little direct empirical evi-
dence concerning the development of early attention skills in
relation to both genetic risk and later symptom profiles for
ASD and ADHD.
Aims of the study and analytical approach
In the present study we aimed to explore analytical approaches for
using developmental endophenotypes to understand pathways to
neurodevelopmental conditions. We operationalized this by
examining if and at what level (liability or later traits) differences
in attention are specifically involved in the developmental path to
ASD and ADHD. To quantify attention, we used eye-tracking to
measure look duration to a selected object or stimulus despite the
presence of distractors. This measure is thought to reflect endog-
enous attention (Conejero & Rueda, 2017; Gliga, Elsabbagh,
Andravizou, & Johnson, 2009) involving processes that require
selective attention and maintenance of engagement to a particular
stimulus as well as inhibition of exogenous effects of the compet-
ing stimuli (Colombo & Cheatham, 2006). Look durations to a
selected object or item in infancy correspond to brain
(event-related potentials of the scalp field) and physiological
(heart rate) measures associated with states of attention
(Richards, 2008). This suggests that this behavioral measure can
be used as an endophenotype because it is closely related to
brain and physiological states in the organism. Moreover, a recent
twin study showed that a large proportion of the variance in how
long toddlers look at areas of a visual scene is genetically related
(Constantino et al., 2017).
Our candidate developmental endophenotype was peak look
duration at faces in an eye-tracking face pop-out task at 14
months of age. We selected this measure because it has already
been well studied in infants with familial liability for ASD (de
Klerk, Gliga, Charman, & Johnson, 2014; Elsabbagh et al., 2013;
Hendry et al., 2018; Wass et al., 2015). Earlier work had suggested
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(counter to expectations) that longer unbroken episodes of look-
ing to faces were present in 18- to 30-month-old children with
ASD relative to neurotypical controls, and that this was dimen-
sionally related to poorer language skills and higher symptom lev-
els within the ASD group (Webb et al., 2010). Interestingly, this
was consistent with the observation that in typical development,
peak unbroken look duration to faces typically decreases in the
infant population across the first year of life and that infants
who do not show this decline also have worse outcomes at 18,
24, and 36 months (Colombo, Shaddy, Richman, Maikranz, &
Blaga, 2004). This early work also showed that typically develop-
ing toddlers with a sibling with an ASD diagnosis also showed a
longer duration of looking to faces than do typically developing
toddlers without an older sibling with ASD, albeit with a smaller
effect size (Webb et al., 2010; see also Jones, Dawson, Kelly, Estes,
& Webb, 2017). This raises the possibility that peak look duration
is an endophenotype that fulfils the criteria for being present in
nonaffected family members at a higher rate than in the typical
population.
We selected the 14-month time-point because prospective
studies have subsequently shown that peak looks to faces within
an array are longer at 14–15 months for infants with older siblings
with ASD than those without. This effect was less pronounced in
the same infants tested at 8 months (Elsabbagh et al., 2013). A
subsequent study with a larger but overlapping cohort indicated
that the effect was only significant at 14 but not 8 months; further,
the change between 8 and 14 months predicted later parent report
of effortful control (Hendry et al., 2018). Indeed, at 6- to
8-months shorter fixation durations in the same task were linked
to later ASD (Wass, Scerif, & Johnson, 2012), suggesting that the
nature of this putative endophenotype may change over the devel-
opmental period in which endogenous influences on visual atten-
tion strengthen (Colombo, 2001). Further, within the group of
infants with older siblings with ASD there were no significant dif-
ferences in peak look to faces at 14 months between children with
and without a later diagnosis of ASD (Elsabbagh et al., 2013 sec-
tion 4.3.2; replicated in an expanded cohort in Hendry et al., 2018,
p. 8). This further supports the evidence from Webb et al. (2010)
that longer peak looks are not driven solely by children with a
diagnostic outcome of ASD, but are rather shared across siblings
as a group. Building on this work, Hendry and colleagues showed
in a partially overlapping cohort that longer looks to faces in
infancy were associated with reduced effortful control in toddler-
hood, suggesting that differences between infants with and with-
out siblings with ASD may be related to their risk for later
effortful control difficulties, rather than categorical ASD
(Hendry et al., 2018). Interestingly, these effects were not observed
in relation to other competing non-social stimuli, possibly indi-
cating that these effects only emerge in response to the stimuli
that primarily capture the attention of infants with and without
later ASD within a particular task (Elsabbagh et al., 2013).
Previous work thus indicates that a longer peak look to faces is
present in typically developing toddlers with a sibling with ASD
(Webb et al., 2010); is present in 14-month-old infants with an
older sibling with ASD and is not specific to later ASD diagnosis
(Elsabbagh et al., 2013; Hendry et al., 2018); emerges between 8
and 14 months (Hendry et al., 2018); and may be dimensionally
related to later effortful control (Hendry et al., 2018). However,
this work thus raises the question: what then is this measure of
visual attention an endophenotype for? Possibly, this disruption
in visual attention does relate to ASD outcome, but sufficient
power is required to demonstrate this. Alternatively, longer peak
looks to faces may relate to conditions that highly co-occur
with ASD but have partially distinct aetiologies, such as ADHD.
This may explain why the association with diagnostic status is
much clearer in clinically referred samples, where co-occurrence
is likely greater (Webb et al., 2010). Alternatively, longer peak
looks may reflect a domain-general protective factor like executive
attention (or effortful control, Hendry et al., 2018) that would be
expected to be impaired in children with both later ASD and
ADHD symptoms.
In the present study, we introduce one operationalization of a
developmental psychopathology framework for beginning to
examine whether longer peak looks to faces are a putative endo-
phenotype for ASD, ADHD, or both. Specifically, in a large sam-
ple we ask whether longer peak looks to faces are related to
specific risk factors or outcome measures of ASD once sample
sizes are large enough; or whether peak looks to faces are related
to specific risk factors or outcome measures of the strongly
co-occurring and aetiologically overlapping condition ADHD;
or whether data are more consistent with peak looks to faces rep-
resenting a general protective factor that acts in the pathway to
both conditions (Johnson et al., 2014). To do this, we use four dif-
ferent approaches: (a) familial liability based on family history
and symptoms in first-degree family members; (b) genetic liability
measured with polygenic scores; (c) temperament traits in tod-
dlerhood which are found in individuals with later symptoms of
the two clinical conditions; (d) elevated ASD and ADHD traits
at 6 years of age.
For familial liability (a), we considered the presence of ASD
and/or ADHD symptomatology in first-degree family members.
This allowed us to identify groups of infants with a familial his-
tory of ASD, ADHD, both conditions and neither. Additionally,
we were interested in complementing the familial liability analysis
by making use of genetic information (b). Genome-wide associa-
tion studies (GWASes)—that test the association between known
variations of the DNA sequence that are common in the popula-
tion and the trait of interest in very large samples—have demon-
strated that many psychiatric conditions, including ASD and
ADHD, are polygenic, meaning that they are influenced by
many common genetic variants each of which has an individually
small effect (Hong et al., 2013; Visscher et al., 2017). However,
even though DNA sequence variants identified in GWASes indi-
vidually have very little effect on outcome, they act independently
and additively and can be aggregated into a single genetic “score,”
termed polygenic score (Dudbridge, 2013). Polygenic scores pro-
vide an individual-specific estimate for genetic propensity for a
phenotypic trait or condition (such as ASD or ADHD), and cor-
respond to the sum of trait-related effects sizes of genetic variants
across the genome identified in the original GWAS (Wray et al.,
2014). The application of polygenic scores has become widespread
in genetic research because they can be utilized to empirically
assess genetic liability for psychiatric conditions, as genetic pre-
dictor variables. We evaluated the association between peak
look duration at the face and polygenic score for ASD and
ADHD. For comparability to the familial liability analysis, we
also took a categorical approach where we identified individuals
who were in the extreme tail of the distribution for ASD/
ADHD polygenic score, considering them at elevated genetic lia-
bility for ASD or ADHD, respectively.
Although endophenotypes can be present when the clinical
symptoms are not, one requirement is that they are linked to a
clinical condition. However, a critical point emerging from studies
of infants with elevated likelihood of ASD is that developmental
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trajectories are dynamic and children show different profiles of
the nature and timing of symptom development (Ozonoff et al.,
2018). Thus, it may be that an endophenotype is stable/state inde-
pendent, but the symptom profile that it is related to changes over
developmental time. At the group level, early signs of emerging
symptomatology can be robustly identified by two years of age
(Ozonoff et al., 2015). However, in some cases clinical manifesta-
tions might not emerge until age five years (Ozonoff et al., 2018).
Moreover, the effect of genetic factors on ASD and ADHD traits,
though present across childhood, becomes stronger with age
(Stergiakouli et al., 2017). One way to capture the link between
genetic factors, developmental endophenotypes and clinical con-
dition even if timing of emergence of the latter is variable is to
test the association between endophenotype and symptom emer-
gence at different time-points in development (Iacono et al.,
2017). In order to evaluate whether our developmental endophe-
notype was informative of the earliest behavioral signs of a neuro-
developmental condition, we then tested whether peak look
duration in infancy was associated with having ASD- and
ADHD-related temperament traits in toddlerhood (c). Previous
research on children with a first-degree relative with ASD and
ADHD has shown that temperament characteristics at 2 years
of age were predictive of later ASD and ADHD symptomatology
(Auerbach et al., 2008; Shephard et al., 2019). In a cohort that is
partly overlapping with the present one, Shephard et al. (2019)
found that high parent-report levels of shyness at 2 years of age
were associated with ASD symptoms in mid-childhood, while
low inhibitory control in toddlerhood was predictive of later
ADHD symptoms (Shephard et al., 2019), in line with other
research (see Visser et al., 2016 for a review). Therefore, we
used these temperament measures as early indicators of clinical
characteristics. Implementing the same categorical approach
that we used in the familial and genetic liability analysis, we
dichotomized parent-report measures of temperament and tested
the effect of elevated ASD and ADHD-related traits in toddler-
hood. Additionally, we tested the linear association between our
candidate developmental endophenotype and parent-report levels
of shyness and inhibitory control at 2 years. Last, we examined
our developmental endophenotype in relation to clinical traits
in mid-childhood (d), when symptoms of neurodevelopmental
conditions usually have clearly emerged (Ozonoff et al., 2018).
We compared children with typical versus elevated ASD/
ADHD, defined based on clinical thresholds for diagnosis for
parent-report questionnaires commonly used in clinical and
research practice: the Social Responsiveness Scale for ASD
(Constantino & Gruber, 2012) and the Conners for ADHD
(Conners, 2008). Additionally, in line with the views of
Beauchaine and Constantino (2017) and Iacono et al. (2017) on
the importance of examining the association between endopheno-
types and dimensional variation in psychiatric traits, we tested the
relationship between peak look duration at the face and continu-
ous ASD and ADHD traits. Finally, to verify the specificity of our
results to the particular a priori measure we selected, we repeated
all analyses for the mean peak look duration across all stimuli.
Materials and methods
Participants
The sample for the present study included 335 participants who
took part in Phase 1, 2, and 3 of the British Autism Study of
Infant Siblings (BASIS, http://www.basisnetwork.org) and
provided eye-tracking data for the face pop-out task at around
14 months of age (M = 14.37, SD = 1.17). The sample from
Phases 1 and 2 included 155 infants with an elevated-likelihood
of developing ASD (EL, 75 females) defined by having at least
one older sibling with a community diagnosis of ASD, and 67
infants with a typical likelihood of developing ASD (TL, 38
females), defined by having at least one older sibling and no fam-
ily history of ASD. Phase 3 participants were recruited for the
Studying Autism and ADHD Risks (STAARS) project, that
included infants with (n = 95, 44 females) and without (n = 18,
7 females) an older sibling or a parent with a community clinical
diagnosis of ASD and/or ADHD or a research classification of
probable ADHD (n = 2; as summarized in Supplementary
Table SM.1 and Methods details section 4). For all Phases, infants
with no family history of ASD or ADHD were recruited from a
volunteer database at the Centre for Brain and Cognitive
Development, Birkbeck University of London and had no
known medical or developmental condition at the time of enrol-
ment. Informed written consent was provided by the parent(s)
prior to the commencement of the study.
Table 1 provides information relative to the number of male
and female participants, peak look duration at the face, age (in
months) and Early Learning Composite and Visual Reception
scores of the Mullen Scales of Early Learning (MSEL) as measures
of developmental level and visual skills, respectively, at the time of
eye-tracking data collection by recruitment group (EL vs. TL).
Supplementary Table SM.2 shows the total number of partici-




The candidate developmental endophenotype used in the present
study consisted of the average peak look duration at the face stim-
ulus across all valid trials of a face pop-out task. The face pop-out
task (described in Elsabbagh et al. (2013) and Gliga et al. (2009))
uses arrays of five pictures presented such that when placed at a
distance of approximately 60 cm from the infant the five individ-
ual pictures on one slide had an eccentricity of 9.3° and covered
an approximate area of 5.2° × 7.3°. The pictures included: a face
with direct gaze, a mobile phone, a bird, a car and a control stim-
ulus defined as “noise” or “scrambled-face,” obtained by random-
izing the phase spectra of the face stimulus while keeping the
amplitude and color spectra constant (Halit, Csibra, Volein, &
Johnson, 2004). An example of the array is presented in Figure 1.
During the task, infants were seated on their caregivers’ lap
approximately 60 cm from the screen. For Phases 1 and 2, a
17-inch monitor with a 5:4 aspect ratio was used. For Phase 3 a
23′′ 16:9 monitor was used and for comparability with previous
phases stimuli were presented within a fixed 17-inches 5:4 virtual
display surrounded by black borders (34.5 cm × 25.9 cm, 32.1° ×
24.4° @ 60 cm viewing distance). All data were acquired on
Tobii infra-red eye trackers (Phase 1, 1750 at 50Hz; Phase 2,
T120 at 60Hz; Phase 3, TX-300 at 120 Hz). Online feedback as
to the position of the child’s eyes relative to the center of the
eye tracker head box allowed experimenters to adjust the position
of the arm-mounted eye trackers for optimal data quality. A five-
point calibration sequence was run and recording only started
when at least four points were successfully calibrated for each
eye. Fourteen (Phase 1), seven (Phase 2) or six (Phase 3) different
slides, containing arrays of five stimuli, were presented for 15 s
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Table 1. Composition characteristics of the participants included in the present study by recruitment group (EL vs. TL) and mean scores of the behavioral measures
collected at 14 months of age.
EL TL Total N
N current study 250 85 335



































































EL: elevated likelihood of autism spectrum disorder (ASD) and/or attention-deficit hyperactivity disorder (ADHD) based on familial history of first-degree family members, TL: typical
likelihood of ASD and/or ADHD based on familial history of first-degree family members, N = number of participants or trials, SD = standard deviation, MSEL: Mullen Scales of Early Learning.
Figure 1. Example of one slide containing an array of five stimuli presented during the face pop-out eye-tracking task.
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each. To ensure that the infant’s gaze was directed to the center, a
small animation was presented in the center of the screen before
each slide presentation. Visual presentation was accompanied by
music to assist infants in maintaining attention throughout the
task. Gaze data were processed using Tobii Studio in Phase 1
(T.G.) and using custom-written MATLAB scripts in Phases 2
and 3 (L.M.). Tobii eye trackers will acquire binocular gaze coor-
dinates where possible, and monocular where only one eye is
detected. The X and Y coordinates of binocular samples were
averaged. Gaze to off-screen locations was marked as missing.
Fixations <100 ms (Phase 1) or <50 ms (Phases 2 and 3) were
removed. For Phases 2 and 3, raw data were first assigned to
Area Of Interests (AOIs). Following this, missing data up to
200 ms were assigned to the AOI if gaps occurred within the
same AOI. In both procedures, where gaps occurred between dif-
ferent AOIs, data were not interpolated.
Each trial was processed, then those with <25% valid samples
or <5 s trial length (due to potential skipping) were marked as
invalid. Only valid trials were included in subject averages.
Subjects with <3 valid trials were excluded from analysis.
For each valid trial, peak look was calculated by taking the
duration of the longest contiguous run of samples within an
AOI (i.e., each look may be formed by multiple fixations, so
long as they occur within an AOI). If no look was available for
a particular stimulus, the trial was excluded from the mean peak
calculations for that AOI. For each participant with at least three
valid trials for the face stimulus (M = 8.38, SD = 3.29, range: 3–14),
an average of peak look duration across trials was calculated and
used as variable in subsequent analyses. The same procedure was
applied to obtain peak look durations to each of the other four stim-
uli. Subsequently, peak look durations were averaged across trials and
further averaged across stimuli in order to obtain a general measure
of sustained attention which was not specific to the social stimulus
(see Supplementary Figure SM.1B).
Peak look durations were averaged across the trials to provide a
more stable characterization of individual differences (Colombo &
Mitchell, 1990; Wass, 2014), and following previous research
(Hendry et al., 2018; Jones et al., 2016). In our sample, peak
look duration was moderately correlated with mean look duration
at the same stimulus (r(1667) = .466, p < .001, for the face stimu-
lus only: r(335) = .460, p < .001). Supplementary Figure SM.1A
shows that the distribution of peak look duration at the face varies
across the three Phases of BASIS. Of note, a different ratio of chil-
dren with and without familial liability for neurodevelopmental
conditions were recruited across Phases. However, Phase had an
effect on peak look duration at the face when restricting the analysis
to TL children (Kruskal–Wallis test: χ2(2) = 13.84, p = .001). While
acknowledging that correcting for Phase could have biased the results
given the different composition of likelihood-groups in the three
cohorts, all subsequent analyses were repeated including Phase as a
covariate to verify whether results were robust to this effect.
Familial liability
Familial liability was defined as having records of ASD or ADHD
symptomatology among first-degree relatives. For ASD, liability
was determined based on parent report of clinical diagnosis
from a UK clinician in at least one of the older siblings (all
Phases, n = 229, where six of the Phase 3 children had also a par-
ent with a condition) or parents (Phase 3 only, n = 21, including
15 where the diagnosis was assigned to parent only and six where
a condition was diagnosed in both parent and sibling, see
Supplementary Table SM.1 for details), supported when possible
with diagnostic letters and questionnaire data. Specifically, a diag-
nosis of ASD was confirmed if the older sibling met the ASD
threshold on the Development and Well-Being Assessment
(DAWBA, Goodman, Ford, Richards, Gatward, & Meltzer,
2000) and/or had a score >15 on the Social Communication
Questionnaire (SCQ, Rutter, Bailey, & Lord, 1993). For ADHD,
parent report of clinical diagnosis of ADHD was required in at
least one of the first-degree family members, or a first-degree rel-
ative had to meet clinical cut-offs on the Conners 3-Parent ques-
tionnaires (Conners, 2008) as outlined in SM 4. Participants were
excluded from this analysis if there was no recent information on
the presence of ADHD traits in the family and no questionnaire
on ADHD available for the older siblings (n = 36 for Phase 1, n
= 14 for Phase 2).
Overall, of the 285 participants who had both valid peak look
at the face data and data on familial liability, 179 had at least one
family member with a diagnosis of ASD (n = 94 EL-ASD + n = 85
EL-ASD/ADHD), 106 had at least one family member with
ADHD (n = 21 EL-ADHD + n = 85 EL-ASD/ADHD) and 85
were TL infants with no familial history of ASD or ADHD in
the first-degree relatives.
Genetic liability
Saliva and/or cheek-swab DNA samples were collected from the
Phase 1, 2, and 3 participants as detailed in the Supplementary
Materials (section 1). Following genotyping and quality control
procedures (summarized in Supplementary Table SM.3), good
quality genetic data were available for 243 BASIS infants of
European ancestry. Polygenic scores for ASD and ADHD were
constructed using LDpred (Vilhjálmsson et al., 2015) based
on the most recent GWASes for ASD and ADHD, both meta-
analyses of data collected by the Lundbeck Foundation
Initiative for Integrative Psychiatric Research (iPSYCH) and
Psychiatric Genomic consortia. Specifically, the ASD GWAS
reports results from 18,382 ASD cases and 27,969 controls
(Grove et al., 2019) while the ADHD GWAS comprised
19,099 ADHD cases and 34,194 controls (Demontis et al.,
2019). Details of polygenic score construction and validation
are reported in the Supplementary Materials (section 2,
Figures SM.2 and SM.3).
Polygenic scores data calculated with PT = 1 were standardized
(ASD: M = 0, SD = 1, range: −2.73 to +3.52; ADHD: M = 0, SD =
1, range:−2.71 to +2.54) and tested for association with peak look
data. Additionally, for the categorical approach illustrated above,
we defined infants as having elevated genetic liability for ASD
or ADHD if they were in the top quartile for ASD and/or
ADHD polygenic score in our sample, respectively. ASD liability
was assigned to individuals who were in the top quartile of the
ASD polygenic score distribution (polygenic score above 0.554).
Similarly, ADHD liability was assigned to individuals in the top
quartile of the ADHD polygenic score (polygenic score above 0.604).
Of the 335 participants with valid peak look duration data, 185
also provided good-quality genotype data for polygenic score
analysis. Of these, 44 were classified as having high ASD genetic
liability (n = 27 ASD + n = 17 ASD/ADHD), 44 as having high
ADHD genetic liability (n = 27 ADHD + n = 17 ASD/ADHD)
and 114 for neither (see Table 3 for descriptives and mean scores).
Supplementary Figure SM.4 illustrates the ASD and ADHD top-
quartile polygenic scores’ thresholds for the individuals with good
quality peak look duration data.
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Toddler temperament traits
The Early Childhood Behavior Questionnaire (ECBQ) was col-
lected for a total of 321 participants across Phases 1, 2, and 3
when they were around 2 years of age (M = 24.87 months,
SD = 1.64). The ECBQ is a parent-report questionnaire designed
to evaluate temperament traits in the first three years of life
(Rothbart, Ahadi, Hershey, & Fisher, 2012). It includes 18 sub-
scales whose scores are constructed by clustering items assessing
different dimensions of temperament (Putnam, Gartstein, &
Rothbart, 2006). For the present research, the shyness subscale
scores (M = 3.32, SD = 1.16, range: 1–7) and the inhibitory control
subscale scores (M = 4.11, SD = 1.18, range: 1–6.6) were used as
indices of temperament traits predictive of later ASD and
ADHD symptomatology, respectively (Shephard et al., 2019; Visser
et al., 2016). Individuals in the top quartile of our sample distri-
bution for shyness (score above 4.00) were classified as having
ASD-related temperament traits; individuals in the bottom
quartile for inhibitory control (score below 3.33) were classified
as having ADHD-related temperament traits in toddlerhood. Of
the 335 participants with valid peak look data, 272 provided
ECBQ data. Of those, 65 had ASD-related temperament traits
(n = 42 ASD + n = 23 ASD/ADHD), 59 had ADHD-related
temperament traits (n = 36 ADHD + n = 23 ASD/ADHD) and
171 neither elevated ASD- or ADHD-related temperament traits
(see Table 3 for descriptives and mean scores, Supplementary
Figure SM.5 for sample characterization based on the quartile
thresholds). Additionally, we tested the linear association between
peak look and ECBQ shyness and inhibitory control scores.
Mid-childhood clinical traits
The second edition of the Social Responsiveness Scale (SRS,
Constantino & Gruber, 2012) School Age version was adminis-
tered to the parents of Phase 1 and 2 infant siblings when they
were 6-year-old (N = 105). This questionnaire provides a quanti-
tative measure of autistic-like behavior that has been extensively
used in both clinically ascertained and population-based samples
of subjects (Constantino & Todd, 2005; Frazier et al., 2014). Raw
scores are converted to t scores to reflect age and gender norms.
The total t score was used as a measure of ASD traits.
The third edition of the Conners Parent form, created to eval-
uate ADHD traits in school-age children aged between 6 and 18
years (Kao & Thomas, 2010), was administered to parents of
Phase 1 and 2 infant siblings when they reached mid-childhood
(N = 103). Additionally, the Conners Early Childhood form was
used for 12 Phase 2 participants who were younger than 6 at
the time of recruitment for this part of the data collection. The
Conners Global Index was computed for the two versions of
the questionnaire. This score is recommended for detailed exam-
ination of ADHD and related features such as executive function-
ing, learning, aggression, hyperactivity/impulsivity, peer relations,
and inattention. For this study, the Global Index total t scores
were calculated and used as a measure of ADHD clinical traits.
The sample for this analysis included 102 participants for
whom both SRS-2 and Conners measures were obtained (mean
age = 6.77, SD = 0.78). Of the 335 participants with valid peak
look duration data, 94 provided both SRS (M = 54.46, SD = 17.04,
range: 38–104) and Conners (M = 57.32, SD = 15.76, range:
40–91) data for this study. Twenty-two participants with SRS
total t score above the standard clinical thresholds for mild to
moderate difficulties in the autism spectrum of 60 were classified
as having elevated ASD traits (n = 6 ASD + n = 16 ASD/ADHD).
Twenty-nine participants scoring above the conventional clinical
threshold of 65 on the Conners Global Index t score were classified
as having elevated levels of ADHD traits (n = 13 ADHD+ n = 16
ASD/ADHD). Fifty-nine participants were considered typically
developing (“neither” group, see Supplementary Figure SM.6).
Table 2 summarizes the variables used and sample sizes for all
the analyses. Table 3 describes the sample and measures divided
into ASD only, ADHD only, ASD/ADHD and neither ASD nor
ADHD liability/traits for the four analyses. A correlation table
between the continuous variables (polygenic scores, toddler tem-
perament traits and mid-childhood clinical traits) can be found in
the Supplementary Materials (Figure SM.7).
Statistical analyses
All analyses were conducted using peak look duration at the face
at 14 months as dependent variable. Peak look data were non-
normally distributed (Shapiro–Wilk normality test: W = 0.879,
p < .001), with the presence of extreme, though plausible, val-
ues. Therefore, the log-transformed peak look data were used
in subsequent analyses. In addition, to test the specificity of
results for the face condition, analyses were repeated using the
log-transformed average peak look duration at all five stimuli
(face, noise, car, phone, and bird) as the dependent variable.
Similarly to other research studying comorbid neurodevelop-
mental disorders (Banaschewski, Neale, Rothenberger, &
Roessner, 2007; Greimel et al., 2011; Tye et al., 2014), we used a
2 × 2 factorial design to evaluate the contribution of the two condi-
tions (additive effects) and of their interaction (multiplicative effect)
to peak look duration. A nonsignificant interaction would provide
evidence in favor of the additive model (Bedford et al., 2014).
Given that our groups were often unbalanced for size, we used
Type II analysis of variance (ANOVAs) to test for the main effects
and interaction effect of having elevated ASD (ASD/ADHD+ASD
vs. ADHD+ neither) or ADHD (ASD/ADHD+ADHD vs. ASD+
neither) familial liability, genetic liability, temperament traits in tod-
dlerhood, and clinical traits in mid-childhood, respectively.
Partial eta-squared (h2p) were used as measures of the effect sizes.
Three linear regressions were used to test for the relationship
between log-transformed peak look data and the continuous var-
iables for genetic liability (ASD and ADHD polygenic scores),
temperament traits in toddlerhood (shyness and inhibitory con-
trol ECBQ scores) and clinical traits in mid-childhood (SRS and
Conners total t scores).
Number of valid trials for the face pop-out task was signifi-
cantly different between recruitment groups (t(132.1) = 5.800, p
< .001, see Table 1) and was thus included as a covariate in all
ANOVA and regression analyses. Age (in months) was also
included as a covariate in all analyses. Additionally, all analyses
were repeated including Phase as a covariate, given the slight dif-
ferences in processing parameters.
Results
Familial liability
Familial liability analyses were conducted on the 285 participants
for whom it was possible to define the presence of ASD and
ADHD in first-degree relatives, as described in the methods sec-
tion. For peak look duration at the face, log-transformed peak
look durations met the assumptions of normality of the distribu-
tion (Shapiro–Wilk test: W = 0.997, p = .801) and homogeneity of
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ADHD: attention deficit-hyperactivity disorder; ASD: autism spectrum disorder; N tot: number of participants with information on the measure of interest; N peak look: number of participants
included in the study as providing both information on the measure of interest and valid peak look at the face data. N (%) ASD: number (percentage of the sample included in the study, i.e.,
N peak look) of participants with elevated ASD liability/traits (ASD + ASD/ADHD); N (%) ADHD: number (percentage of the sample included in the study) of participants with elevated ADHD
liability/traits (ADHD + ASD/ADHD); GWAS: Genome-Wide Association Study; ECBQ: Early Childhood and Behavior Questionnaire; SRS: Social Responsiveness Scale.
Table 3. Descriptives and mean scores of the measures used in the four analyses by group: attention-deficit hyperactivity disorder (ADHD) liability/traits only,
autism spectrum disorder (ASD) only, both ASD and ADHD (ASD/ADHD) and neither. Results of the analysis of variance (ANOVAs) comparing the four groups are
reported for the continuous measures.
ADHD ASD ASD/ADHD Neither ANOVA
Familial liability N 21 94 85 85
Males/females 14/7 44/50 50/35 40/45
Genetic liability N 27 27 17 114
Males/females 10/17 16/11 11/6 62/52






















N 36 42 23 171























































N 13 6 16 59


































ECBQ: Early Childhood and Behavior Questionnaire; MSEL: Mullen Scales of Early Learning; SRS: Social Responsiveness Scale.
a,b,c,dDifferent superscript letters denote that groups are significantly different from each other based on Tukey’s Honest Significant Difference post-hoc analyses with 95% family-wise
confidence level.
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variance (Levene’s test: F(3,281) = 2.010, p = .113). There was a
significant main effect of having a family history of ADHD (F
(1,279) = 4.150, p = .043, h2p = 0.015), but not of ASD (F(1,279)
= 0.757, p = .385, h2p = 0.003). Similarly, the nonsignificant result
of the interaction term did not support a multiplicative effect of
having elevated familial liability for both conditions on peak
look duration at the face (F(1,279) = 0.340, p = .528, h2p = 0.001).
When removing Phase as a covariate, we found no significant
main effect of having a family history of ASD (F(1,277) = 0.129,
p = .719, h2p < 0.001) or ADHD (F(1,277) = 1.162, p = .282, h
2
p =
0.004) and no significant interaction between ASD and ADHD
(F(1,277) = 0.578, p = .448, h2p = 0.002). To further explore
whether our results were due to the fact that Phase 3 only
included individuals with familial liability for ADHD and not
ASD, we repeated the analyses in the Phase 3 cohort only.
Results confirmed there was no main effect of either condition
(ASD: F(1,107) = 1.136, p = .289, h2p = 0.010, ADHD: F(1,107) =
1.767, p = .187, h2p = 0.016), nor significant interaction between
ASD and ADHD (F(1,107) = 1.536, p = .218, h2p = 0.218).
For mean peak look duration at all stimuli, analyses revealed
that was no significant effect of ASD (F(1,279) = 0.730, p = .394,
h2p = 0.003; with Phase as covariate: F(1,277) = 1.105, p = .294,
h2p = 0.004), ADHD (F(1,279) = 0.338, p = .562, h
2
p = 0.001; with
Phase as covariate: F(1,277) = 0.425, p = .515, h2p = 0.002) and no
significant interaction effect (F(1,279) = 0.649, p = .421, h2p = 0.002;
with Phase as covariate: F(1,277) = 0.023, p = .880, h2p < 0.001).
Genetic liability
Genetic liability analyses were conducted on the subset of 185
participants who provided good-quality genotype data for poly-
genic score analysis. Log-transformed peak look duration at the
face data had a normal distribution (W = 0.994, p = .619) and
homogeneous variance between groups (F(3,181) = 1.328, p
= .267). Our categorical analysis revealed that there was a signifi-
cant main effect of increased genetic liability for ADHD (F
(1,179) = 4.05, p = .045, h2p = 0.021), but not for ASD (F(1,179)
= 0.017, p = .898, h2p < 0.001, Figure 2). The interaction effect
was also non-significant (F(1,179) = 0.809, p = .370, h2p = 0.005),
indicating that having increased polygenic factors for both condi-
tions did not influence peak-look durations at the face. When
including Phase as a covariate, peak look duration at the face
was not significantly different between infants with and without
elevated polygenic score for ASD (F(1,177) = 0.017, p = .895, h2p
< 0.001) or ADHD (F(1,177) = 1.623, p = .204, h2p = 0.009). The
interaction term was also nonsignificant (F(1,177) = 1.274, p
= .260, h2p = 0.007). When examining the linear relationship
with the two polygenic scores, we found that peak look duration
at the face was significantly associated with polygenic score for
ADHD (β = 0.078, standard error = 0.034, p = .023, Figure 3;
with Phase as covariate: β = 0.068, SE = 0.032, p = .035) but not
for ASD (β = 0.002, SE = 0.034, p = .944; with Phase as covariate:
β = 0.006, SE = 0.033, p = .864).
When examining mean peak look to all stimuli, our categorical
analysis revealed that there was no significant main effect of hav-
ing elevated ASD (F(1,179) = 0.341, p = .559, h2p = 0.002) or
ADHD genetic liability (F(1,179) = 0.402, p = .527, h2p = 0.002)
and no significant interaction effect (F(1,179) = 2.108, p = .148,
h2p = 0.012). The same pattern of results was found when
including Phase as a covariate (ASD: F(1,177) = 0.033, p = .857,
h2p < 0.001; ADHD: F(1,177) = 0.269, p = .605, h
2
p = 0.002;
ASD*ADHD: F(1,177) = 1.963, p = .163, h2p = 0.011). When
testing their linear relationship, we found no association between
mean peak look duration at all stimuli and polygenic score
for ASD (β = 0.005, SE = 0.021, p = .805; with Phase as covariate:
β = <0.001, SE = 0.020, p = .993) and ADHD (β = 0.006, SE =
0.021, p = .781; with Phase as covariate: r = .008, SE = 0.020,
p = .682).
Toddler temperament traits
Of the 335 infants with valid peak look data at 14 months, 272
also had ECBQ scores at 2 years. For these children, log-
transformed peak look durations were normally distributed
(W = 0.997, p = .918) and variance homogenous between groups
for the 2 × 2 factorial design (F(3,268) = 1.286, p = .279). We
found that having elevated levels of shyness at two years was
not significantly associated with peak look duration (F(1,266) =
0.739, p = .391, h2p = 0.003, with Phase as covariate: F(1,264) =
0.055, p = .815, h2p < 0.001). There was also no effect of having ele-
vated ADHD-related temperament traits, that is poor inhibitory
control (F(1,266) = 1.311, p = .253, h2p = 0.005, with Phase as
covariate: F(1,264) = 0.269, p = .605, h2p = 0.001) and interaction
result did not support a multiplicative model where having ele-
vated traits in both conditions significantly related to peak look
duration (F(1,266) = 0.603, p = .438, h2p = 0.002, with Phase as
covariate: F(1,264) = 0.534, p = .465,h2p = 0.0012).
The lack of evidence for an association between peak look
durations at the face at 14 months and the selected temperament
traits at 2 years was confirmed by the results of the multiple
regression including continuous ECBQ shyness (β =−0.004, SE
= 0.023, p = .850; with Phase as covariate: β = 0.014, SE = 0.022,
p = .537) and inhibitory control scores (β =−0.030, SE = 0.027,
p = .274; with Phase as covariate: β =−0.010, SE = 0.027, p = .703).
For mean peak look at all the stimuli in the array, we found no
main effect of having elevated ASD traits (F(1,266) = 0.217, p
= .642, h2p < 0.001, with Phase as covariate: F(1,264) = 0.592, p
= .442, h2p = 0.002) nor ADHD traits (F(1,266) = 1.235, p = .267,
h2p = 0.005, with Phase as covariate: F(1,264) = 0.839, p = .361,
h2p = 0.003). Further, there was no significant interaction effect
(F(1,266) = 0.086, p = .770, h2p < 0.001, with Phase as covariate:
F(1,264) = 0.101, p = .751, h2p < 0.001). While there was no linear
association between mean peak look duration at all stimuli and
ECBQ shyness scores (β = −0.011, SE = 0.015, p = .471, with
Phase as covariate: β =−0.013, SE = 0.015, p = .392), we found
that longer looking times at the stimuli in the array at 14 months
of age was associated with reduced inhibitory control at 2 years (β
=−0.038, SE = 0.017, p = .029). However, this result was not con-
firmed from the analyses which included Phase as a covariate (β =
−0.026, SE = 0.018, p = .146).
Mid-childhood clinical traits
With our categorical approach, we tested whether peak look dura-
tion at the face in infancy was associated with elevated levels of
ASD and/or ADHD clinical traits during mid-childhood defined
using conventional clinical thresholds of the SRS and Conners
Global Index total t scores (Figure 4) in 94 children with available
questionnaire data at 6 years of age. The log-transformed peak
look duration data had normal distribution (W = 0.988, p
= .577) and equal variance between groups (F(3,90) = 0.607, p
= .612). We found a trend of association between peak look dura-
tion at the face in infancy and elevated ASD traits at 6 years (F
(1,88) = 3.218, p = .076, h2p = 0.035), which became statistically
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significant when including Phase as covariate (F(1,87) = 4.202, p
= .043, h2p = 0.046). Longer peak look duration at the face was
observed in infants who later showed elevated ADHD traits (F
(1,88) = 6.401, p = .013, h2p = 0.068, with Phase as covariate: F
(1,87) = 4.948, p = .029, h2p = 0.053). The interaction effect was
not significant, indicating that children with elevated levels of
traits of both ASD and ADHD at 6 years did not show a specific
pattern of peak look duration at the face in infancy (F(1,88) =
Figure 2. Mean peak look duration at the face for
infants with elevated genetic liability of autism spec-
trum disorder (ASD), attention-deficit hyperactivity dis-
order (ADHD) or neither conditions. The peak look
duration values presented on the y-axis are log-
transformed and adjusted for the effect of number of
valid trials and age. Error bars represent ±1 standard
error of the mean. All individual data are represented
by points (elevated-likelihood of ASD and/or ADHD
(EL)) or triangles (typical-likelihood of ASD and/or
ADHD (TL)) and color-coded based on whether the
infant had typical genetic liability (green), polygenic
score in the top quartile for ASD only (brick), polygenic
score in the top quartile for ADHD only (yellow), or poly-
genic score in the top quartile for both ASD and ADHD
(orange).
Figure 3. Linear relationship between peak look dura-
tion at the face (on the y-axis) and attention-deficit
hyperactivity disorder (ADHD) polygenic score (on the
x-axis). Peak look duration values are log-transformed
and adjusted for the effect of number of valid trials
and age. The shaded area around the black regression
line represents the standard error of the beta estimate.
All individual data are represented by points (elevated-
likelihood of ASD and/or ADHD (EL)) or triangles (typi-
cal-likelihood of ASD and/or ADHD (TL)) and color-
coded based on whether the infant had typical genetic
liability (green), polygenic score in the top quartile for
ASD only (brick), polygenic score in the top quartile
for ADHD only (yellow), or polygenic score in the top
quartile for both ASD and ADHD (orange). Color-coded
regression lines for each of these subgroups are also
presented in the figure.
Figure 4. Mean peak look duration at the face for
infants with typical development and children with ele-
vated autism spectrum disorder (ASD) or attention-
deficit hyperactivity disorder (ADHD) traits in mid-
childhood. The peak look duration values presented
on the y-axis are log-transformed and adjusted for the
effect of number of valid trials and age. Error bars rep-
resent ±1 standard error of the mean. All individual data
are represented by points (elevated-likelihood of
ASD and/or ADHD (EL) or triangles (typical likelihood
of ASD and/or ADHD (TL)) and color-coded based on
whether the infant had typical development (green),
scored above the ASD threshold only in the
parent-report questionnaire (brick), scored above the
ADHD threshold only in the parent-report questionnaire
(yellow), or scored above the threshold for both ASD
and ADHD (orange) at 6 years of age.
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0.049, p = .826, h2p < 0.001, with Phase as covariate: F(1,87) =
0.018, p = .893, h2p < 0.001).
When examining the linear relationship with continuous t
scores, we found no association with SRS t scores (β = −0.003,
SE = 0.004, p = .271; with Phase as covariate: β =−0.004, SE =
0.003, p = .237) and a trend of positive association with Conners
Global Index t scores (β = 0.007, SE = 0.004, p = .083) which was
weaker when including Phase as a covariate (β = 0.005, SE =
0.004, p = .163).
Analyses on mean peak look duration at all the stimuli in the
pop-out array revealed that there was no significant main effect of
ASD (F(1,88) = 1.575, p = .213, h2p = 0.018) or ADHD (F(1,88) =
1.803, p = .183, h2p = 0.020) outcome in mid-childhood.
Additionally, there was no significant interaction effect (F(1,88)
= 0.045, p = .832, h2p < 0.001). All these results were confirmed
when including Phase as a covariate in the ANOVA models
(ASD: F(1,87) = 1.790, p = .184, h2p = 0.020; ADHD: F(1,87) =
1.351, p = .248, h2p = 0.015; ASD*ADHD: F(1,87) = 0.066, p = .798,
h2p < 0.001).
No significant associations were found between mean peak
look duration and the SRS (β = −0.003, SE = 0.002, p = .181;
with Phase as covariate: β =−0.003, SE = 0.002, p = .174) or
Conners (β = 0.004, SE = 0.003, p = .176; with Phase as covariate:
β = 0.003, SE = 0.003, p = .243) total t scores.
Discussion
The focus of this study was to develop a new framework for
assessing how infant metrics reflecting emerging components of
cognition might relate to different susceptibility and outcome pro-
files and how they can be used to study specificity of developmen-
tal trajectories, and thereby to evaluate whether they partially
fulfil criteria for endophenotypes. As a proof-of-principle, we
looked at early attention in the pathway to ASD and ADHD in
infants considered at elevated likelihood of ASD and ADHD
because of the presence of these conditions in first-degree family
members. A series of analyses were conducted to investigate the
relationship between familial and genetic liability factors, looking
behavior in a face pop-out task recorded with eye-tracking at 14
months of age and later behavioral signs of the two neurodevelop-
mental conditions. Longer peak look duration at the face was
found in infants with elevated polygenic score for ADHD, but
not ASD. Further, longer peak look duration at the face in infancy
was significantly associated with increased severity of ADHD
traits in mid-childhood, while a weaker association was found
with later ASD traits.
Overall, these findings suggest that peak look duration at the
face amongst distractor items at the beginning of the second
year of life should be further investigated as a specific develop-
mental endophenotype of ADHD, as it is linked to genetic factors
and to later traits associated with a clinical condition (Iacono
et al., 2017). Further work should now explore whether it further
co-segregates with categorical diagnosis of ADHD, and whether it
is elevated in categorically unaffected siblings of children with
ADHD as it is in typically developing children with an older sib-
ling with ASD (Webb et al., 2010). The statistical models used in
the present study provided no evidence of an additive or multipli-
cative effect of ASD, indicating that the presence of liability or
emerging traits of both conditions was not predictive of atypical
looking behavior to faces more than the effects of liability and
traits of ADHD alone. However, there was also a marginally sig-
nificant association between early peak look to faces and later
elevated ASD traits categorically (though not dimensionally, and
the categorical effect was only significant when Phase was con-
trolled). Below we present further considerations on the results
obtained in this study and discuss possible models for the devel-
opment of psychopathology arising from combining different type
of data and multiple observations across childhood.
Polygenic effects
To validate a measure as an endophenotype, it is crucial to verify
that it not only reflects increased familial liability for a clinical
condition, but it also has a molecular genetic basis (Iacono
et al., 2017). To this aim, we tested whether polygenic scores
for ASD and ADHD explained any of the variance seen in our
candidate developmental endophenotype, peak look duration at
the face at 14 months of age. Polygenic scores, in which the effects
of genotypes at many locations across the genome are summed,
are increasingly used to query the genetic architecture of psycho-
logical traits and their correlates, where many genes of very small
effect are responsible for heritability (Plomin, 2013). To our
knowledge, no studies have investigated polygenic contributions
to infant behavioral endophenotypes. However, there is suggestive
evidence that polygenic scores for psychiatric conditions are sig-
nificantly associated with neuroanatomical markers of atypical
development in infants (Cullen et al., 2019) and with continuous
phenotypes relying on social attention skills (Warrier et al., 2018)
and cognitive test scores (Hagenaars et al., 2016) in childhood.
Taken together, these and our findings suggest that characteriza-
tion of genetic liability in (necessarily smaller) deeply phenotyped
prospective longitudinal cohorts will be a powerful way in which
to explore the developmental paths to neurodevelopmental and
psychiatric conditions.
The present results demonstrated that polygenic contribution
to our candidate developmental endophenotype was highest
when considering common variants associated with ADHD.
The base GWAS used for ADHD polygenic score calculation
(Demontis et al., 2019) is larger (by ∼700 cases and ∼6,000 con-
trols) than the one currently available for ASD (Grove et al.,
2019). Moreover, while a polygenic score obtained from the
ASD GWAS predicts 2.45% of the variability in the ASD clinical
phenotype (Grove et al., 2019), the ADHD polygenic score
explains around 5.5% of the variance in categorical diagnosis of
ADHD (Demontis et al., 2019) in large populations. Thus, it is
possible that the present result simply reflects the greater predic-
tive power of a polygenic score obtained from the ADHD GWAS
summary statistics, rather than indicating genetic specificity. It
will be important to confirm whether the variance in peak look
duration explained by the ASD polygenic score increases as larger
discovery GWASes for ASD are reported and more powerful poly-
genic scores emerge (Anney et al., 2017; Geschwind & Konopka,
2009). Further, it should be noticed that GWASes capture com-
mon genetic contributions to clinical conditions identified in
adult populations, which might not necessarily be informative
of developmental effects.
In the main analyses looking at genetic liability as a categorical
variable, we found that being in the top quartile of the distribu-
tion for ADHD polygenic score was significantly associated
with peak look duration. Further, when examining the linear asso-
ciation between polygenic score and the continuous endopheno-
type obtained in the score construction (section 2 of the
Supplementary Materials), we saw that the aggregate effect of var-
iants known to be associated with ADHD predicted maximum
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1.7% of the variance in peak look duration at the face in the
BASIS infants. This effect is undoubtedly very small in absolute
terms, and is unlikely to have clinical utility. However, if put in
the context of similar research, the amount of variance explained
is higher than that observed in studies using polygenic scores to
predict ASD-relevant continuous traits tested during childhood
in large cohorts. For example, an ASD polygenic score predicted
1.3% of the variance in autistic traits at 8 years of age (St Pourcain
et al., 2018) in a sample of 5,553 children. A polygenic score for
cognitive empathy significantly predicted 0.3% of the variance in
the performance in a computerized test of “theory of mind” abil-
ities in 4,577 13-year-olds (Warrier & Baron-Cohen, 2018). Our
data suggest that a categorical approach comparing groups indi-
viduals at low and elevated genetic liability (i.e., the latter being
defined as those at the tail of the polygenic score distribution,
see also Li, 2019) could help identifying elements of atypical
development that should be targeted by symptomatology-specific
intervention (Jeste & Geschwind, 2014).
The effect of polygenic scores should not be considered an
exhaustive evaluation of the genetic contributions to the examined
developmental endophenotype. A more precise picture of genetic
effects would be provided by assessing whether rarer genetic
variants (including inherited and de novo copy number variants,
or CNVs) also account for part of the variability seen in
infant peak look duration. First-degree relatives of individuals
with ASD have an increased rate of rare genetic variants and
advanced paternal age is also associated with an increased risk
of de novo mutations (Iossifov et al., 2012; Leppa et al., 2016);
given the established role of de novo CNVs in liability to ASD,
this is an avenue worth exploring in studies of infants at elevated
likelihood of ASD. In the future, comprehensive genetic
characterization of longitudinal infant cohorts would allow
researchers to conduct a more powerful validation of develop-
mental endophenotypes and provide more accurate information
about the contribution of the full spectrum genetic factors under-
lying the emergence of psychopathology (Dick, 2018; Iacono
et al., 2017).
Combining data to understand mechanisms
Examining the role of developmental endophenotypes in the
pathway to neurodevelopmental conditions might inform on pro-
cesses occurring during specific developmental periods when
genetic factors have more powerful effects. Based on previous
studies specifically examining infant peak look duration at faces
(Hendry et al., 2018; Jones et al., 2017; Webb et al., 2010), we pre-
dicted that longer looking time in infancy would have been asso-
ciated with behavioral characteristics of neurodevelopmental
conditions later in childhood. Indeed, we found that longer
peak look duration at 14 months of age related to both increased
genetic vulnerability for ADHD and later ADHD clinical manifes-
tations (Kao & Thomas, 2010). This is consistent with another
study showing that infant siblings of children with ASD who
later received a diagnosis of ADHD presented longer look dura-
tions at the screen during an eye-tracking task from three months
of age compared to children without ADHD, and no change in
duration across the first two years of life (Miller, Iosif, Young,
Moore Hill, & Ozonoff, 2018). Thus, longer peak look durations
in infancy could reflect genetically driven atypicalities of brain
structure or function resulting in domain-general problems
which affect sensory processing and attentional control often
seen in individuals with ASD and ADHD (Gliga, Jones,
Bedford, Charman, & Johnson, 2014; Piven, Elison, & Zylka,
2017; Polderman et al., 2013).
Indeed, hypoactivation of brain networks involved in attention
and executive functioning has been consistently reported by func-
tional magnetic resonance imaging (fMRI) studies in children and
adults with ADHD (Cortese et al., 2012). In line with the idea that
longer look durations relate to emerging difficulties in executive
functioning, in a previous study on a subset of the present cohort,
change in peak look duration between 9 and 15 months signifi-
cantly predicted later effortful control skills, whereby children
with weaker effortful control at three years of age showed a
smaller decline in peak look duration at faces with age in infancy
(Hendry et al., 2018). A possible explanation for these findings
could be that in the face pop-out task children with stronger
attentional control became more successful (i.e., faster) in shifting
the gaze away from the face stimulus and directing it to the other
stimuli in the array in the second year of age. Similarly, in an
independent typical-likelihood population, shorter duration of
looks during infancy predicted better inhibitory control in adoles-
cence (Sigman, Cohen, & Beckwith, 1997), providing further evi-
dence of a possible link between early look duration profiles and
emerging executive function (Conejero & Rueda, 2017). Of note,
our toddlerhood analyses did not reveal a significant association
between look duration at 14 months and inhibitory control at 2
years of age. As the effect of genotype in neurodevelopmental tra-
jectories becomes stronger with age across childhood (Stergiakouli
et al., 2017), our candidate developmental endophenotype might
indeed reflect an effect of ADHD-related genetic variants that is
only emerging later in development. A further critical question
will be to address whether looking profiles may associate differen-
tially with later ADHD across development. Indeed, previous
work has linked shorter look durations measured in the first few
months of life to later ASD (Wass et al., 2015) and ADHD
(Papageorgiou, Farroni, Johnson, Smith, & Ronald, 2015).
Developmental shifts in looking profiles are likely underpinned
by the changing hegemony of the endogenous and exogenous
attentional control systems over looking behavior (Colombo,
2001; Hendry, Johnson, & Holmboe, 2019). Within a develop-
mental psychopathology framework, atypicalities may manifest
in different ways at different ages. Statistical techniques designed
to ask whether later effects are causally mediated through earlier
effects will be important in this area.
When considering possible mechanisms linking early peak
look duration profiles and ADHD it is worth notice that our
results were specific to faces. Control analyses revealed that no sig-
nificant relationships were observed when examining mean peak
look duration at all the stimuli. Notably, infants generally looked
longer at the face in the arrays presented in our study (see
Supplementary Figures SM.1A and SM.1B). The face likely thus
captured attention more strongly, which may have made it harder
for infants to disengage from it to orient to distractor objects (see
also Colombo et al., 2004). In fact, infants’ arousal levels during
alerting influence their ability to orient attention towards a stim-
ulus among distractors (Kleberg, del Bianco, & Falck-Ytter, 2019).
Thus, dysfunctional modulation in the alerting network may
influence attentional capacity especially for faces, that are possibly
over-arousing stimuli given their complex nature (Keehn, Müller,
& Townsend, 2013; Senju & Johnson, 2009). Of note, an adult
study reports dysregulation in the alerting systems and more dis-
tractibility due to conflicting stimuli in individuals with ADHD
who also showed signs of mood disorder (Lundervold et al.,
2011). We might have observed a similar pattern in our infants
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who later showed elevated ADHD traits using the face pop-out
task. Moreover, aggregate effects of genetic variants involved in
the dopamine/norepinephrine neurotransmission (regulating the
alerting attention system, see Petersen & Posner, 2012) were spe-
cifically associated with severity of symptoms in the hyperactive/
impulsive domain in children with ADHD (Bralten et al., 2013).
Thus, our findings could reflect ADHD-related atypicalities in
the alerting system due to genetic factors that lead to difficulties
in disengaging from the face to direct attention to competing
stimuli. Further investigations on the role of the alerting system
in individuals at elevated genetic liability for ADHD should
include multiple neurocognitive measures to disentangle the dif-
ferent aspects of selective attention involved in the developmental
endophenotype analyzed in the current study (Beauchaine &
Constantino, 2017; Hommel et al., 2019).
This proof-of-principle study could help us to shed light on
the overlap and specificity of developmental pathways to ASD
and ADHD. In our sample, we found a high correlation between
dimensional levels of ADHD and ASD traits at age 6 years (see
Supplementary Figure SM.7), in line with previous reports
(Chien et al., 2017; Shephard et al., 2019; Stergiakouli et al.,
2017). However, while overlap of behavioral profiles is seen in
mid-childhood, our results revealed that atypical look duration
at the face among distractors is associated with later ADHD,
while the link with later ASD is less strong (though possibly con-
founded by cohort-specific differences). This pattern of results
indicates that our candidate developmental endophenotype
could be more closely involved in the development of ADHD pro-
files. The fact that we saw little overlap between groups defined for
the four levels of analysis (i.e., familial liability, genetic liability,
toddler temperament traits, and mid-childhood clinical traits)
indicates that in our sample elevated genetic liability for ADHD
did not necessarily lead to high levels of ADHD traits in mid-
childhood. Indeed, individual developmental paths result from
cascades of processes interacting across childhood (Marechal
et al., 2007) and timing of genetic and environmental influences
determines the effect of their contribution to trajectories over
the course of development (Panchanathan & Frankenhuis,
2016). In one of their models of the developmental emergence
of behavioral symptoms of ASD, ADHD and co-occurrence of
the two conditions, Johnson et al. (2014) hypothesized that com-
mon susceptibility factors generate common adaptive processes
that, depending on the developmental periods in which they are
activated, produce condition-specific outcomes (Johnson et al.,
2014). The approach proposed in this study could be further
expanded leveraging data collected at multiple time-points within
infant-sibling studies to explore longitudinal changes in the con-
tribution of developmental endophenotypes to neurodevelopmen-
tal conditions.
Another of the models proposed by Johnson et al. (2014)
assumes that, while susceptibility factors as well as early signs
that precede symptoms are condition-specific, the relation
between these and future outcome depends on the presence of
general protective factors. Thus, either ASD, ADHD or overlap-
ping symptomatology might emerge depending on the interaction
with a domain-general protective factor. The proposition that our
candidate endophenotype could reflect individual differences in
executive functioning could be interpreted according to this
model. In fact, Johnson (2012) theorized that executive function
skills have a protective value across neurodevelopmental condi-
tions, as individuals with strong executive function skills might
be better able to compensate for early neural atypicalities related
to presence of susceptibility factors (Johnson, 2012). Indeed,
although peak look duration was specifically related to polygenic
risk scores for ADHD and not ASD, the relation with mid-
childhood traits of ASD was also significant if Phase was con-
trolled. These findings provide preliminary evidence that should
encourage future research to specifically test whether executive
function skills mediate between ADHD-specific genetic liability
factors and later broad neurodevelopmental traits.
Taken together, our results suggest that longer peak look dura-
tion at the face in infancy is a promising developmental endophe-
notype of ADHD, possibly reflecting enhanced vulnerability in
early visual attention due to ADHD-related genetic factors that
might affect alerting and/or executive function and contribute
to the consolidation of ADHD-related behavioral features
(Johnson et al., 2014). As we showed in this proof-of-principle,
investigating the relationship between early signs of atypical
behavior, molecular genetics data and later behavioral traits
might advance our knowledge on mechanisms underlying neuro-
developmental conditions.
What is familial liability?
Our methodological approach for this analysis might not be very
sensitive in capturing the different aspects that contribute to fami-
lial liability effects. In the present study, “familial liability” was
measured as the presence of ASD and/or ADHD symptomatology
in one of the first-degree family members reported by parents.
While this approach has been widely used to obtain a proxy of
increased genetic predisposition to psychopathology, it does not
allow us to disentangle how different elements of the familial
environment of the individual contribute to shaping their devel-
opmental trajectory. Individuals within the same family share
not only part of their DNA sequence, but also the same rearing
and socioeconomic environment. While examining the relation-
ship between developmental endophenotypes and the presence
of diagnosis in first-degree family members could serve as initial
step of analysis, considerations on our results suggest that future
investigations should aim to disentangle the different factors con-
tributing to or confounding the effect of bio-ecological contexts
underlying familial liability.
Differently from previous reports analyzing overlapping
cohorts of Phase 1 and 2 participants (Elsabbagh et al., 2013;
Hendry et al., 2018), in our study we did not find evidence for
an association between familial liability for ASD and peak look
duration at the face in a face pop-out task in the second year of
age. However, we found that familial liability for ADHD was asso-
ciated with the same measure. This result was not robust to
including Phase as a covariate in the analysis nor when examining
only the Phase 3 sample (which was the only cohort with individ-
uals classified as having familial liability for ADHD but not ASD).
This indicates that the observed result might primarily derive
from having familial liability for the two neurodevelopmental
conditions in the older sibling. Of note, recurrence for these neu-
rodevelopmental conditions within families can vary by degree of
relatedness (see Franke et al., 2012; Sandin et al., 2015). In fact,
parental nonshared genetic variants (Kong et al., 2018), indirect
effects of parental genome (Wertz et al., 2019) as well as par-
ent–sibling relationships (Oliver & Alison, 2018) can have specific
effects on the offspring’s psychological traits. Future analyses
should aim to study each element specifically to deeply under-
stand whether any of these play an additional role that comple-
ment the effect of aggregate polygenic variation.
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Limitations and further considerations for future research
A first challenge of this project was to reduce differences between
Phases when defining familial liability groups. Our choice was to
exclude the participants for whom we had no recent parent-report
information on the presence of ADHD traits in the family, if no
questionnaire on ADHD was available for the older siblings. This
indeed led to the exclusion of a potentially informative subset of
the sample and introduces additional risk of selection bias in our
cohort (Wolke et al., 2009). Moreover, for one of the cohorts
(Phase 3), our recruitment criteria were based on the presence
of one of the two clinical conditions in the individual’s parent
and/or an older sibling. As recurrence might change by degree
of relatedness and different mechanisms be involved in this pro-
cess, as discussed above, future studies aiming to investigate these
should consider eliminating or controlling for this difference.
Using registries of routinely collected health data in large-scale
cohorts might help to understand family-level differences and
to identify potential confounders when examining effects of fami-
lial liability (Fearon, 2019).
In the present study, to have a consistent approach when eval-
uating ASD and ADHD-related liability and traits using data from
different sources, we applied a categorical approach dichotomiz-
ing continuous variables used to measure the degree of ASD
and ADHD liability/symptomatology. While pre-defined thresh-
olds for ASD and ADHD clinical characterization exist for SRS
and Conners total t scores, which were used to assess traits at
age 6 years, there were no previous indications from normative
samples for condition cut-offs for the polygenic and ECBQ scores.
Therefore, we assigned, for each of the polygenic and ECBQ
scores, value of 1 to ASD and ADHD dummy variables for indi-
viduals in the extreme quartile of the distribution. This approach
allowed us to obtain a discrete number of individuals in each
group and to use a unique method to define elevated genetic
and behavioral burden for neurodevelopmental conditions.
However, our quartile thresholds were based on all available
BASIS data of each specific measure and are necessarily relative
to the current sample. Given that the BASIS sample is mainly
composed by individuals at elevated likelihood of ASD and/or
ADHD, a replication on a population-based sample would be
ideal to validate our results.
Another limitation of the present study is that clinical ASD
and ADHD diagnosis was not available for a proportion of the
participants. While recent revisions of the endophenotype con-
cept suggested that examining relationships with dimensional
transdiagnostic traits could provide more generalizable informa-
tion on the role and clinical utility of candidate developmental
endophenotypes (Beauchaine & Constantino, 2017; Iacono
et al., 2017), a validation based on DSM diagnosis, as required
by the original framework (Gottesman & Gould, 2003), was not
possible in the present sample. This limitation indicates that
future work using designs with diagnostic outcome will be
required before peak looking duration as a condition-specific
developmental endophenotype can be verified.
Importantly, observations on looking behavior based on the
face pop-out screen-based paradigm used in the present study
cannot be directly interpreted as endogenous attention directed
to people during social interactions. Wass (2014) found that indi-
vidual differences in peak look duration recorded with eye-
tracking from 11-month-old typically developing infants were
consistent across static and dynamic screen stimuli but were unre-
lated to individual differences in looking behavior during free play
with objects. Indeed, susceptibility to high luminance contrasts
and sudden changes in stimulus onset–offset may trigger individ-
ual differences on screen-based tasks, but are not relevant in more
naturalistic context. In the latter, the complexity of the visual
scene might have a different impact to looking behavior compared
to the limited number of uncontrolled distractors in screen-based
tasks (Wass, 2014). These considerations illustrate that in future
research it will be important to further investigate to what extent
the measures selected as candidate developmental endopheno-
types of neurodevelopmental conditions reflect responses
obtained in ecologically valid contexts. Importantly, peak look
duration differed by Phase and interpreting the effect of Phase
is complicated in the BASIS sample. As explained in the
Supplementary Methods section 4, Phases differed in the ratio
of individuals with familial history for the conditions as well as
in some aspects of the face pop-out task, and on the visit protocol
the pop-out task was embedded. In this study, we considered as
“robust” the results that were significant with and without the
inclusion of Phase as a covariate. While combining cohorts in
order to obtain large sample sizes may be advantageous to obtain-
ing sufficient power and generalizability for the study of endophe-
notypes (Dick, 2018), this challenges researchers in finding ways
to deal with between-cohort differences.
Accuracy and precision of eyetracking data were only recorded
in the Phase 3 sample, but show that the quality of at least this
proportion of the data is sufficient for the metrics calculated
(see Supplementary Figure SM.9). While these metrics are impor-
tant when interpreting the results of AOI analyses, we believe that
the face pop-out task is relatively protected against spatial error
for two reasons. First, the stimuli were large (∼3.5°–9°) and
arranged in an annular array, with a minimum separation (between
closest edges) of ∼3.5°. Even in cases of particularly poor calibra-
tion, accuracy drift of this magnitude would be substantial and is
not expected. Second, the arrangement of each AOI within the
annular array was balanced across slides. The influence of system-
atic spatial error should therefore not bias the results toward any
particular AOI once averaged across all trials.
Conclusions
The present study combines three different cohort datasets of eye-
tracking measures as well as genotype data and parent-report
questionnaire data for over 300 infants with and without a first-
degree family member with ASD or ADHD. We found that
early alterations in visual attention, represented by longer look
durations at face images among other items at 14 months of
age, may lie on the path from genetic liability for ADHD to
later traits of this condition, and that the early part of this devel-
opmental trajectory is not shared with ASD. Thus, a phenotype
previously noted in elevated-likelihood infants as a group related
to genetic risk for ADHD and later ADHD traits, although this
emerged only by looking at symptoms in mid-childhood. This
proof-of-principle study highlighted the importance of measuring
multiple traits and having long-term follow-up data to uncover
the role of developmental endophenotype on the trajectory to
psychopathology. Future studies should use neurocognitive
marker tasks (Beauchaine & Constantino, 2017) and longitudinal
models (Dick, 2018; Fearon, 2019; Johnson et al., 2014) to evalu-
ate the relationship between domain-general processes and early
signs of divergent developmental trajectories.
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